Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

Abroad (travel likely)RecruitingPHASE4

Conditions

Gonorrhea Male · Chlamydia (Male) · Syphilis Male

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Anza Mapema Clinic, Kisumu, Kenya
Contact: Study coordinator (Fredrick O Otieno, PhD MPH) · fotieno@nrhskenya.org · 254572024065
Contact: Study coordinator (Carol Agwanda) · cagwanda@nrhskenya.org · 254725323274
Contact: Principal Investigator (Fredrick O Otieno, PhD MPH)
University of Washington/Pwani Research Centre at the Ganjoni Municipal Clinic, Mombasa, Mombasa, Kenya
Contact: Study coordinator (Eduard J Sanders, MD PhD) · ejs45@uw.edu · 254 723 593762
Contact: Study coordinator (R. Scott McClelland, MD MPH) · mcclell@uw.edu · 2064730392
Contact: Principal Investigator (Eduard J Sanders, MD PhD)
R. Scott McClelland, MD MPH (Sub-investigator)
TRANSFORM Clinic, Nairobi, Kenya
Contact: Study coordinator (Joshua Kimani, MBChB, MPH) · Jkimani@phdaf.org · +254 20 210 1155
Contact: Study coordinator (Rhoda W Kabuti, MBChB) · rwanjiru@phdaf.org · +254 20 210 1155
Contact: Principal Investigator (Joshua Kimani, MBChB MPH)

Study leads

Susan M Graham, MD, PhD, MPH
Principal Investigator
University of Washington

View source on ClinicalTrials.gov